Aptamer Group plc, the leading developer of next-generation synthetic binders delivering innovation to the life science industry, today announced the launch of its biomarker discovery service, ...
Conscience, a non-profit focused on accelerating drug discovery in areas of unmet medical need using open science and radical collaboration, is pleased to announce three recipients and projects have ...
Artificial intelligence and polyclonal antibody sequencing redefine the future of antibody discovery
insights from industryDr. Xiabing HanPrincipal Scientist for Antibody DiscoveryRapid Novor In this interview, News-Medical had the opportunity to speak with Dr. Xiaobing Han, Principal Scientist for ...
with insights into Evotec and our capabilities. This edition features Evotec’s PanOmics-driven drug discovery approach, the impact of precision medicine approaches, and the software platform PanHunter ...
After training as a mathematician and physicist, Felix Wong, PhD, developed a keen interest in biology. He found the perfect fit in the lab of James J. Collins, PhD, at MIT, where he started using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback